EPISODE · Jul 18, 2026 · 7 MIN
今天3分钟我们来聊聊回输50亿NK细胞后，60例恶性肿瘤患者整体生存质量显著改善，免疫功能也提升
from 源于细胞BioInsid的个人播客
国内一项60例恶性肿瘤患者NK细胞回输研究显示，患者生存质量显著提升，免疫功能改善，且安全性良好。研究虽有局限，但为NK细胞在肿瘤治疗中的定位提供了方向。 参考文献： 湖北省荆门市第一人民医院血液科. 回输NK细胞治疗恶性肿瘤患者60例的临床研究. 2013-2014. European Organisation for Research and Treatment of Cancer. QLQ-C30 quality of life questionnaire. 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊回输50亿NK细胞后，60例恶性肿瘤患者整体生存质量显著改善，免疫功能也提升
0:00
7:17
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 7 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on July 18, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!